Global Cord Blood Overview

Global Cord Blood EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CO.

Quarterly EBIT

$142.14M

↓ 9.21% YoY

As of Jul 5, 2022

Annual EBIT (TTM)

$594.45M

↑ 4.67% YoY

Trailing 12 months ending Jul 5, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin